Once-Daily Versus Four-Times-Daily Intravenous Busulfan with Therapeutic Drug Monitoring as Conditioning for Hematopoietic Cell Transplantation in Children.

Pharmaceutics · 2025 · PMC12389012 · PMID 40871100

Europe PMC DOI

hedged sentence

0.1190

closest p · 2.4× alpha

0.1190

boldest claim

The sentences

did not reach statistical significancep = 0.119not close (p > 0.1)

A higher BSA appeared to be associated with a lower hazard of events (HR = 0.021; 95% CI = 0.000–2.722), but this did not reach statistical significance ( p = 0.119).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.